These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38847283)

  • 1. Assessing Photostability of mAb Formulations In Situ Using Light-Coupled NMR Spectroscopy.
    Bramham JE; Wang Y; Moore SA; Golovanov AP
    Anal Chem; 2024 Jun; 96(24):9935-9943. PubMed ID: 38847283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation.
    Doshi N; Giddings J; Luis L; Wu A; Ritchie K; Liu W; Chan W; Taing R; Chu J; Sreedhara A; Kannan A; Kei P; Shieh I; Graf T; Hu M
    Pharm Res; 2021 Mar; 38(3):531-548. PubMed ID: 33713012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR spectroscopy as a characterization tool enabling biologics formulation development.
    Ma J; Pathirana C; Liu DQ; Miller SA
    J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing monoclonal antibody formulations in arginine glutamate solutions using
    Kheddo P; Cliff MJ; Uddin S; van der Walle CF; Golovanov AP
    MAbs; 2016 Oct; 8(7):1245-1258. PubMed ID: 27589351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranking mAb-excipient interactions in biologics formulations by NMR spectroscopy and computational approaches.
    Zhang C; Gossert ST; Williams J; Little M; Barros M; Dear B; Falk B; Kanthe AD; Garmise R; Mueller L; Ilott A; Abraham A
    MAbs; 2023; 15(1):2212416. PubMed ID: 37218059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photosensitizers form in histidine buffer and mediate the photodegradation of a monoclonal antibody.
    Stroop SD; Conca DM; Lundgard RP; Renz ME; Peabody LM; Leigh SD
    J Pharm Sci; 2011 Dec; 100(12):5142-55. PubMed ID: 21786276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Excipients on Freeze-dried Monoclonal Antibody Formulation Degradation and Sub-Visible Particle Formation during Shaking.
    Jin MJ; Ge XZ; Huang Q; Liu JW; Ingle RG; Gao D; Fang WJ
    Pharm Res; 2024 Feb; 41(2):321-334. PubMed ID: 38291165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of polysorbate 80 quality on photostability of a monoclonal antibody.
    Singh SR; Zhang J; O'Dell C; Hsieh MC; Goldstein J; Liu J; Srivastava A
    AAPS PharmSciTech; 2012 Jun; 13(2):422-30. PubMed ID: 22362139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Use Photostability Practice and Regulatory Evaluation for Pharmaceutical Products in an Age of Light-Emitting Diode Light Sources.
    Allain LR; Pierce BC; Wuelfing WP; Templeton AC; Helmy R
    J Pharm Sci; 2019 Mar; 108(3):1172-1176. PubMed ID: 30315811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photostability and interaction of ascorbic acid in cream formulations.
    Ahmad I; Sheraz MA; Ahmed S; Shaikh RH; Vaid FH; ur Rehman Khattak S; Ansari SA
    AAPS PharmSciTech; 2011 Sep; 12(3):917-23. PubMed ID: 21735345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cis/Trans Isomerization of Unsaturated Fatty Acids in Polysorbate 80 During Light Exposure of a Monoclonal Antibody-Containing Formulation.
    Prajapati I; Peters BH; Larson NR; Wei Y; Choudhary S; Kalonia C; Hudak S; Esfandiary R; Middaugh CR; Schöneich C
    J Pharm Sci; 2020 Jan; 109(1):603-613. PubMed ID: 31715179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edetate Disodium as a Polysorbate Degradation and Monoclonal Antibody Oxidation Stabilizer.
    Yarbrough M; Hodge T; Menard D; Jerome R; Ryczek J; Moore D; Baldus P; Warne N; Ohtake S
    J Pharm Sci; 2019 Apr; 108(4):1631-1635. PubMed ID: 30502482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies.
    Zhang H; Hong S; Tan SSK; Peng T; Goh LYH; Lam KH; Chow KT; Gokhale R
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visible light triggers the formation of reactive oxygen species in monoclonal antibody formulations.
    Hipper E; Diederichs T; Kaiser W; Lehmann F; Buske J; Hinderberger D; Garidel P
    Int J Pharm; 2024 Jun; 661():124392. PubMed ID: 38942184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Grinding-Induced Subvisible Particles and Free Radicals in a Freeze-Dried Monoclonal Antibody Formulation.
    Jing ZY; Huo GL; Sun MF; Shen BB; Fang WJ
    Pharm Res; 2022 Feb; 39(2):399-410. PubMed ID: 35083639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freeze-Dried Biopharmaceutical Formulations are Surprisingly Less Stable than Liquid Formulations during Dropping.
    Fang WJ; Pang MJ; Liu JW; Wang X; Wang H; Sun MF
    Pharm Res; 2022 Apr; 39(4):795-803. PubMed ID: 35314998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of D-Amino Acids in Light Exposed mAb Formulations.
    Bommana R; Subelzu N; Mozziconacci O; Sreedhara A; Schöneich C
    Pharm Res; 2018 Oct; 35(11):238. PubMed ID: 30334107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis methods of polysorbate 20: A new method to assess the stability of polysorbate 20 and established methods that may overlook degraded polysorbate 20.
    Khossravi M; Kao YH; Mrsny RJ; Sweeney TD
    Pharm Res; 2002 May; 19(5):634-9. PubMed ID: 12069166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of UV Radiation on the Degradation of Pharmaceutical Formulations Containing Quercetin.
    Golonka I; Wilk S; Musiał W
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.